In vitro antimicrobial activity of volatile organic compounds from Muscodor crispans against the pathogenic oomycete

Theerapong Krajaejun1, Tassanee Lowhnoo, Wanta Yingyong

  • 1Department of Pathology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. mr_en@hotmail.com

Insights

Volatile organic compounds (VOCs) from the fungus Muscodor crispans B23 show potent antimicrobial activity against Pythium insidiosum. This discovery offers a promising avenue for treating pythiosis, a dangerous infection resistant to conventional drugs.

Area of Science:

  • Mycology
  • Oomycete Pathogenesis
  • Antimicrobial Discovery

Background:

  • Pythium insidiosum causes life-threatening pythiosis in humans, resistant to standard antifungal treatments.
  • Endophytic fungi, like Muscodor crispans, produce volatile organic compounds (VOCs) with known antimicrobial properties.

Purpose of the Study:

  • To investigate the in vitro efficacy of synthetic VOCs from Muscodor crispans strain B23 against clinical and environmental isolates of Pythium insidiosum.
  • To determine the dose-dependent inhibitory and lethal effects of these VOCs on Pythium insidiosum.

Main Methods:

  • Testing a synthetic mixture of VOCs from Muscodor crispans B23 against 30 isolates of Pythium insidiosum (25 human, 1 animal, 4 environmental).
  • Evaluating growth inhibition and lethality at varying VOC concentrations (2.5, 10.0, and 20.0 microl), with a no-drug control group.

Main Results:

  • The B23 VOC mixture significantly inhibited growth (≥80%) of all Pythium insidiosum isolates at low doses (2.5 microl).
  • Complete growth inhibition was observed at 10.0 microl, and lethality was confirmed at 20.0 microl, demonstrating a dose-dependent effect.
  • The synthetic B23 VOCs exhibited both inhibitory and lethal effects across all tested Pythium insidiosum isolates.

Conclusions:

  • Synthetic VOCs from Muscodor crispans B23 possess significant in vitro inhibitory and lethal activity against Pythium insidiosum.
  • These findings suggest a potential novel therapeutic strategy for pythiosis, warranting further investigation.
  • The study highlights the potential of fungal VOCs as an alternative treatment for infections caused by drug-resistant oomycetes.